The cost of type 1 diabetes: a nationwide multicentre study in Brazil
OBJECTIVE: To determine the direct medical costs of type 1 diabetes mellitus (T1DM) to the National Brazilian Health-Care System (NBHCS) and quantify the contribution of each individual component to the total cost. METHODS: A retrospective, cross-sectional, nationwide multicentre study was conducted...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The World Health Organization
2013-06-01
|
| Series: | Bulletin of the World Health Organization |
| Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862013000600011&lng=en&tlng=en |
| _version_ | 1827333669426036736 |
|---|---|
| author | Roberta Arnoldi Cobas Marcos Bosi Ferraz Alessandra Saldanha de Mattos Matheus Lucianne Righeti Monteiro Tannus Carlos Antonio Negrato Luiz Antonio de Araujo Sergio Atala Dib Marilia Brito Gomes |
| author_facet | Roberta Arnoldi Cobas Marcos Bosi Ferraz Alessandra Saldanha de Mattos Matheus Lucianne Righeti Monteiro Tannus Carlos Antonio Negrato Luiz Antonio de Araujo Sergio Atala Dib Marilia Brito Gomes |
| author_sort | Roberta Arnoldi Cobas |
| collection | DOAJ |
| description | OBJECTIVE: To determine the direct medical costs of type 1 diabetes mellitus (T1DM) to the National Brazilian Health-Care System (NBHCS) and quantify the contribution of each individual component to the total cost. METHODS: A retrospective, cross-sectional, nationwide multicentre study was conducted between 2008 and 2010 in 28 public clinics in 20 Brazilian cities. The study included 3180 patients with T1DM (mean age 22 years ± 11.8) who were surveyed while receiving health care from the NBHCS. The mean duration of their diabetes was 10.3 years (± 8.0). The costs of tests and medical procedures, insulin pumps, and supplies for administration, and supplies for self-monitoring of blood glucose (SMBG) were obtained from national and local health system sources for 2010-2011. Annual direct medical costs were derived by adding the costs of medications, supplies, tests, medical consultations, procedures and hospitalizations over the year preceding the interview. FINDINGS: The average annual direct medical cost per capita was 1319.15 United States dollars (US$). Treatment-related expenditure - US$ 1216.33 per patient per year - represented 92.20% of total direct medical costs. Insulin administration supplies and SMBG (US$ 696.78 per patient per year) accounted for 52.82% of these total costs. Together, medical procedures and haemodialysis accounted for 5.73% (US$ 75.64 per patient per year) of direct medical costs. Consultations accounted for 1.94% of direct medical costs (US$ 25.62 per patient per year). CONCLUSION: Health technologies accounted for most direct medical costs of T1DM. These data can serve to reassess the distribution of resources for managing T1DM in Brazil's public health-care system. |
| first_indexed | 2024-03-07T17:32:47Z |
| format | Article |
| id | doaj.art-24ca61629de34836acbdbf6d3b308e3d |
| institution | Directory Open Access Journal |
| issn | 0042-9686 |
| language | English |
| last_indexed | 2024-03-07T17:32:47Z |
| publishDate | 2013-06-01 |
| publisher | The World Health Organization |
| record_format | Article |
| series | Bulletin of the World Health Organization |
| spelling | doaj.art-24ca61629de34836acbdbf6d3b308e3d2024-03-02T17:30:47ZengThe World Health OrganizationBulletin of the World Health Organization0042-96862013-06-0191643444010.2471/BLT.12.110387S0042-96862013000600011The cost of type 1 diabetes: a nationwide multicentre study in BrazilRoberta Arnoldi Cobas0Marcos Bosi Ferraz1Alessandra Saldanha de Mattos Matheus2Lucianne Righeti Monteiro Tannus3Carlos Antonio NegratoLuiz Antonio de Araujo4Sergio Atala Dib5Marilia Brito Gomes6State University Hospital of Rio de JaneiroUniversidade Federal de São PauloState University Hospital of Rio de JaneiroState University Hospital of Rio de JaneiroJoinville Endocrinology and Diabetes InstituteUniversidade Federal de São PauloState University Hospital of Rio de JaneiroOBJECTIVE: To determine the direct medical costs of type 1 diabetes mellitus (T1DM) to the National Brazilian Health-Care System (NBHCS) and quantify the contribution of each individual component to the total cost. METHODS: A retrospective, cross-sectional, nationwide multicentre study was conducted between 2008 and 2010 in 28 public clinics in 20 Brazilian cities. The study included 3180 patients with T1DM (mean age 22 years ± 11.8) who were surveyed while receiving health care from the NBHCS. The mean duration of their diabetes was 10.3 years (± 8.0). The costs of tests and medical procedures, insulin pumps, and supplies for administration, and supplies for self-monitoring of blood glucose (SMBG) were obtained from national and local health system sources for 2010-2011. Annual direct medical costs were derived by adding the costs of medications, supplies, tests, medical consultations, procedures and hospitalizations over the year preceding the interview. FINDINGS: The average annual direct medical cost per capita was 1319.15 United States dollars (US$). Treatment-related expenditure - US$ 1216.33 per patient per year - represented 92.20% of total direct medical costs. Insulin administration supplies and SMBG (US$ 696.78 per patient per year) accounted for 52.82% of these total costs. Together, medical procedures and haemodialysis accounted for 5.73% (US$ 75.64 per patient per year) of direct medical costs. Consultations accounted for 1.94% of direct medical costs (US$ 25.62 per patient per year). CONCLUSION: Health technologies accounted for most direct medical costs of T1DM. These data can serve to reassess the distribution of resources for managing T1DM in Brazil's public health-care system.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862013000600011&lng=en&tlng=en |
| spellingShingle | Roberta Arnoldi Cobas Marcos Bosi Ferraz Alessandra Saldanha de Mattos Matheus Lucianne Righeti Monteiro Tannus Carlos Antonio Negrato Luiz Antonio de Araujo Sergio Atala Dib Marilia Brito Gomes The cost of type 1 diabetes: a nationwide multicentre study in Brazil Bulletin of the World Health Organization |
| title | The cost of type 1 diabetes: a nationwide multicentre study in Brazil |
| title_full | The cost of type 1 diabetes: a nationwide multicentre study in Brazil |
| title_fullStr | The cost of type 1 diabetes: a nationwide multicentre study in Brazil |
| title_full_unstemmed | The cost of type 1 diabetes: a nationwide multicentre study in Brazil |
| title_short | The cost of type 1 diabetes: a nationwide multicentre study in Brazil |
| title_sort | cost of type 1 diabetes a nationwide multicentre study in brazil |
| url | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862013000600011&lng=en&tlng=en |
| work_keys_str_mv | AT robertaarnoldicobas thecostoftype1diabetesanationwidemulticentrestudyinbrazil AT marcosbosiferraz thecostoftype1diabetesanationwidemulticentrestudyinbrazil AT alessandrasaldanhademattosmatheus thecostoftype1diabetesanationwidemulticentrestudyinbrazil AT luciannerighetimonteirotannus thecostoftype1diabetesanationwidemulticentrestudyinbrazil AT carlosantonionegrato thecostoftype1diabetesanationwidemulticentrestudyinbrazil AT luizantoniodearaujo thecostoftype1diabetesanationwidemulticentrestudyinbrazil AT sergioataladib thecostoftype1diabetesanationwidemulticentrestudyinbrazil AT mariliabritogomes thecostoftype1diabetesanationwidemulticentrestudyinbrazil AT robertaarnoldicobas costoftype1diabetesanationwidemulticentrestudyinbrazil AT marcosbosiferraz costoftype1diabetesanationwidemulticentrestudyinbrazil AT alessandrasaldanhademattosmatheus costoftype1diabetesanationwidemulticentrestudyinbrazil AT luciannerighetimonteirotannus costoftype1diabetesanationwidemulticentrestudyinbrazil AT carlosantonionegrato costoftype1diabetesanationwidemulticentrestudyinbrazil AT luizantoniodearaujo costoftype1diabetesanationwidemulticentrestudyinbrazil AT sergioataladib costoftype1diabetesanationwidemulticentrestudyinbrazil AT mariliabritogomes costoftype1diabetesanationwidemulticentrestudyinbrazil |